Celsius Therapeutics Company
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2018-01-01
Last Funding Date:
2022-03-24
Total Funding:
148000000.0
Technology:
['BioTech & HealthTech']
Employee Number:
45200
Estimated Revenue:
$1M to $10M
Investors Number:
11.0
Industry:
Medical BioTech